Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
NASDAQ:VVOS
Price:
2.45 USD
6.52%
Market Closed
Updated:
Jun 10, 2024
Vivos Therapeutics Inc
Other Current Liabilities
|
Vivos Therapeutics Inc
Other Current Liabilities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Other Current Liabilities
$2.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Other Current Liabilities
$942.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Other Current Liabilities
$2.4B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Other Current Liabilities
$33.3B
|
CAGR 3-Years
34%
|
CAGR 5-Years
24%
|
CAGR 10-Years
32%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Current Liabilities
$377.5m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
47%
|
See Also
What is Vivos Therapeutics Inc's Other Current Liabilities?
Other Current Liabilities
2.3m
USD
2.3m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Other Current Liabilities amounts to 2.3m USD.
What is Vivos Therapeutics Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
21%
21%
Over the last year, the Other Current Liabilities growth was -24%. The average annual Other Current Liabilities growth rates for Vivos Therapeutics Inc have been -7% over the past three years , 21% over the past five years .
You don't have any saved screeners yet
